Biosecure Act Excluded from Defense Bill, Boosting Chinese Biotech
TL;DR Summary
A proposed biosecurity bill aimed at regulating Chinese biotech contractors, such as WuXi AppTec, was not included in the end-of-year defense package, which was considered its best opportunity for passage in the current session of Congress.
- Biosecure bill is left out of end-of-year defense package, dealing blow to chances Endpoints News
- Biosecure Act Out of Key Defense Bill in Win for Chinese Biotech Bloomberg
- Biosecure Act MIA from US defense bill in key win for China biopharma service providers FiercePharma
- Biosecure Act left out of defense authorization bill Axios
- BIOSECURE Act, aimed at Chinese drug manufacturers, is dealt a major blow STAT
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
36%
56 → 36 words
Want the full story? Read the original article
Read on Endpoints News